EnWave Closes Private Placement With Director

EnWave Corporation (TSX VENTURE:ENW)(FRANKFURT:E4U) ("EnWave", or the "Company")
is pleased to announce that, further to its news release on June 23rd, 2014, it
has closed a non-brokered private placement with Mr. John P.A. Budreski, raising
CAD$150,000 through the issuance of 111,111 common shares at a price of $1.35
per common share. The common shares have a four-month hold period expiring on
October 24, 2014. The proceeds are to be used for working capital and general
corporate purposes.


About EnWave 

EnWave Corporation is a Vancouver-based industrial technology company developing
commercial applications for its proprietary Radiant Energy Vacuum (REV(TM))
dehydration technology. EnWave aims to sign royalty-bearing commercial licenses
with leading food and pharmaceutical companies for the use of its revolutionary
technology. Thus far the Company has signed ten royalty-bearing licenses,
opening up eight distinct market sectors for commercialization with companies
that include Bonduelle, a global leader in the production of vegetables; Hormel
Foods Corporation, a major processed meat manufacturer in the United States of
America; and Sutro Biopharma, a company developing a protein synthesis process
for the pharmaceutical industry. In addition to these licenses, EnWave has
formed a Limited Liability Partnership, NutraDried LLP, to develop, manufacture,
market and sell all-natural cheese snack products in the United States under the
Moon Cheese(R) brand. The Company has also signed a license and manufacturing
agreement with NutraDried Creations to market the dried cheese and other REV(TM)
snack products through private label distribution channels in the United States
and Latin America.


EnWave has signed a wide range of research agreements with an expanding list of
companies that include Nestle, Kellogg's, Ocean Spray Cranberries, Sun-Maid
Growers, R.J. Reynolds and Merck among others. EnWave is introducing REV(TM) as
a new dehydration standard in the food and biological material sectors:
potentially faster and cheaper than freeze drying, with better end product
quality than air drying or spray drying.


EnWave currently has six REV(TM) platforms: commercial-scale nutraREV(R) and
MIVAP(R) are used in the food industry to dry food products quickly and at
low-cost, while maintaining high levels of nutrition, taste, texture and colour.
The Company has also commercialized powderREV(R) for bulk dehydration of food
cultures, probiotics and fine biochemicals such as enzymes below the freezing
point; quantaREV(TM) for continuous, high-volume low-temperature drying; and
bioREV(TM) and freezeREV(TM) as new methods to stabilize and dehydrate
biopharmaceuticals such as vaccines and antibodies. More information about
EnWave is available at www.enwave.net. 


EnWave Corporation

Dr. Tim Durance, President, CEO & Director

Safe Harbour for Forward-Looking Information Statements: This press release may
contain forward-looking information based on management's expectations,
estimates and projections. All statements that address expectations or
projections about the future, including statements about the Company's strategy
for growth, product development, market position, and expected expenditures, are
forward-looking statements. These statements are not a guarantee of future
performance and involve a number of risks, uncertainties and assumptions.
Although the Company has attempted to identify important factors that could
cause actual results to differ materially, there may be other factors that cause
results not to be as anticipated, estimated or intended. There can be no
assurance that such statements will prove to be accurate, as actual results and
future events could differ materially from those anticipated in such statements.
Accordingly, readers should not place undue reliance on forward-looking
statements.


Neither the TSX Venture Exchange nor its Regulation Services Provider (as that
term is defined in the policies of the TSX Venture Exchange) accepts
responsibility for the adequacy or accuracy of this release.


FOR FURTHER INFORMATION PLEASE CONTACT: 
EnWave Corporation
Mr. John Budreski
Executive Chairman
([phone]
[e-mail]


EnWave Corporation
Mr. Brent Charleton
Vice President, Corporate Affairs
([phone]
[e-mail]
www.enwave.net